HHS seeks feedback from entities in HIPAA audit program

The Department of Health and Human Services (HHS) is seeking feedback from entities on their involvement in a 2012 Office of Civil Rights HIPAA audit program. Survey results will inform the HHS as it embarks on a permanent program, as required by the HITECH Act.

A March 19 Federal Register notice requested feedback n the agency’s intent to conduct an online survey of 115 health plans, healthcare clearinghouses and healthcare providers audited in the program. The survey would:

  • ask entities to measure the program’s effectiveness;
  • gauge attitudes about the program and its features (document requests, communications received, the on-site visit, audit-report findings and recommendations);
  • obtain estimates of incurred costs, both in time and money;
  • seek feedback on the program’s impact on day-to-day business operations; and
  • assess whether the program led to improvements in HIPAA compliance.

In particular, the notice requests comment from the public regarding to the burden estimate of the proposed surveys. A copy of the notice is here.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.